New China Life Insurance
¥56.35Change from previous close: +0.73%Absolute change: +¥0.41
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ¥175.79B
- Enterprise value
- -¥456.9B
- P/E (trailing 12 months)
- 3.97
- Forward P/E
- 6.06
- PEG
- 0.57
- Price/book
- 1.42
- Price/sales
- 2.12
- EV/EBITDA
- -9.01
- EV/revenue
- -5.50
Profitability and growth
- Gross margin
- 64.4%
- Operating margin
- 65.8%
- Net margin
- 53.3%
- ROE
- 42.8%
- ROA
- 1.7%
- Revenue growth (year over year)
- 39.1%
- Earnings growth (year over year)
- 83.7%
Financial health
- Total cash
- ¥797.54B
- Total debt
- ¥164.82B
- Debt/equity
- 1.33
- Current ratio
- 5.04
- Quick ratio
- 4.96
Dividends
- Annual dividend per share
- ¥2.73
- Dividend yield
- 4.8%
- Payout ratio
- 18.7%
- Ex-dividend date
- August 7, 2026
Analysts and estimates
- Average price target
- ¥64.67
- Median price target
- ¥64.30
- High price target
- ¥82.00
- Low price target
- ¥38.60
- Analysts with a price target
- 10
- Forward EPS
- ¥9.30
- EPS estimate, current year
- ¥10.82
Shares and trading
- Beta
- 0.81
- Average volume
- 19.76M
- Shares outstanding
- 2.09B
- Float
- 2.73B
- Institutional ownership
- 7.4%
- Insider ownership
- 66.7%
